Pharma Pulse 12/16/24: Dark Chocolate Lowers T2D Risk, Technology Accessibility & more

Peer Exchange: Technology Accessibility

In the fifth and final part of this roundtable discussion, participants discuss the practice of designing technology with patients in mind and share their concluding thoughts on improving diversity in clinical trials.

Study: Dark Chocolate Consumption Lowers Risk of Type 2 Diabetes

Dark chocolate consumption has been associated with a lower risk of type 2 diabetes (T2D), but this association was not seen with milk chocolate, according to results of a study published in BMJ.

Why Hackers Want Your Health Information

Health records contain personal information that can leave patients exposed to financial and medical risks.

Gilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief Medical Officer

Gilead Sciences, Inc. announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical Officer and will become a member of Gilead’s senior leadership team. Dr. Berger succeeds Merdad Parsey, MD, PhD.

The Axia Institute - Michigan State University on LinkedIn

In the third part of Pharmaceutical Commerce Magazine's "Peer Exchange: RFID Testing and Experimentation" podcast, Axia's Bahar Aliakbarian, PhD, shares how Axia Lab conducts fundamental research of RFID tags and describes the pilot research being conducted on the feasibility of RFID for pharmaceutical traceability. Axia regularly tests inlay tag designs to determine if pharmaceutical formulations affect a tag performance. The pilot research, initiated by Axia in cooperation with industry partners, identified more than a 99% read-rate in a pilot study completed in 2023. Phase II, a real-world pilot, is underway and expected to be complete in Fall 2025. https://lnkd.in/gEsfmiWN

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs